These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4067854)

  • 1. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.
    Pitha J; Pitha J
    J Pharm Sci; 1985 Sep; 74(9):987-90. PubMed ID: 4067854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous water-soluble cyclodextrin derivatives: 2-hydroxyethyl, 3-hydroxypropyl, 2-hydroxyisobutyl, and carboxamidomethyl derivatives of beta-cyclodextrin.
    Irie T; Fukunaga K; Yoshida A; Uekama K; Fales HM; Pitha J
    Pharm Res; 1988 Nov; 5(11):713-7. PubMed ID: 3247276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic cyclodextrin derivatives enable effective oral administration of steroidal hormones.
    Pitha J; Harman SM; Michel ME
    J Pharm Sci; 1986 Feb; 75(2):165-7. PubMed ID: 3958926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexation of several drugs with water-soluble cyclodextrin polymer.
    Szeman J; Ueda H; Szejtli J; Fenyvesi E; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):282-8. PubMed ID: 3594657
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
    Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
    J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of cyclodextrin inclusion complexes: II--Inclusion complexes between alpha-cyclodextrin and N-desmethyldiazepam and chlordiazepoxide.
    Aboutaleb AE; Abdel Rahman A; Samy EM
    J Pharm Belg; 1988; 43(6):437-44. PubMed ID: 3150006
    [No Abstract]   [Full Text] [Related]  

  • 13. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.
    Tokumura T; Ueda H; Tsushima Y; Kasai M; Kayano M; Amada I; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4179-84. PubMed ID: 6529813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 15. The investigation of cyclodextrin polymer as a new disintegrant for direct compressed tablets.
    Sekulović D; Zajić L
    Pharmazie; 1987 Aug; 42(8):556. PubMed ID: 3432343
    [No Abstract]   [Full Text] [Related]  

  • 16. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases.
    Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H
    J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
    Frank SG; Kavaliunas DR
    J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solute-induced circular dichroism: complexation of achiral drugs with cyclodextrin.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2822-5. PubMed ID: 6524657
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxypropyl-beta-cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity.
    Müller BW; Brauns U
    J Pharm Sci; 1986 Jun; 75(6):571-2. PubMed ID: 3735101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.